Reference - Detail
|Author||Myoken Y, Kyo T, Fujihara M, Sugata T, Mikami Y.|
|Title||Clinical significance of breakthrough fungemia caused by azole-resistant Candida tropicalis in patients with hematologic malignancies.|
A 5-year retrospective analysis of fungemia in patients with hematologic malignancies revealed that four patients, who received fluconazole and itraconazole during neutropenia, developed breakthrough candidemia due to azole-resistant Candida tropicalis isolates. This observation suggests that causative organisms of candidemia in neutropenic patients receiving azoles should be suspected of being azole-resistant.
|MeSH||Adult Aged Antifungal Agents / therapeutic use* Azoles / therapeutic use* Candida tropicalis / drug effects* Candidiasis / drug therapy Candidiasis / microbiology* Drug Resistance, Microbial Female Fungemia / drug therapy Fungemia / microbiology* Hematologic Neoplasms / immunology* Hematologic Neoplasms / microbiology Humans Male Middle Aged Neutropenia / complications Retrospective Studies|
|Pathogenic microorganisms||C. tropicalis?|